These findings suggest that chronic activation of RASFs by RANTES/CCL5 or cytokines such as IL-1β during the disease progression leads to the subtle structural changes in the native collagen of the cartilage that eventually contribute to the tissue destruction in RA. The gene discussed is CCL5; the disease is rheumatoid arthritis.